Toxic Substructure Extraction via Clustering and Scaffold Analysis
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods in pharmacokinetics for discovering novel compounds are resource-intensive and slow, with existing machine learning techniques failing to effectively identify promising drug candidates due to limited data sets and ineffective methods.
Innovation Solution
A system and method that utilizes a substructure extraction module to analyze molecular structure data and properties, such as ADMET, EC50, and IC50, to identify substructures causing or not causing specific properties, filtering out harmful molecules and creating datasets of active/inactive substructures, employing a scaffold extraction module and comparison module to determine bioactivity effects.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If empirical experimentation methods are used to discover novel compounds, then reliable pharmacological properties can be obtained, but the process becomes resource intensive and extremely slow
Solution Approach 1:
The patent creates virtual copies of molecular structures through computational modeling and machine learning algorithms. Instead of physically synthesizing and testing every possible compound, the system generates digital representations and predicts their pharmacological properties, dramatically reducing the time and resources required while maintaining reliable property assessment through validated predictive models
Solution Approach 2:
The patent replaces the mechanical/physical experimentation system with a computational information processing system. Machine learning models and algorithms substitute for physical laboratory experiments, enabling the system to evaluate pharmacological properties of novel compounds in silico rather than requiring resource-intensive wet lab experiments for each candidate
2Productivity
If machine learning techniques are used to discover novel compounds, then productivity increases, but the techniques fail to effectively identify promising candidates due to limited data sets and ineffective methods
Solution Approach 1:
The patent performs preliminary actions by pre-processing and curating molecular structure data before main analysis. The system prepares comprehensive training datasets with known pharmacological properties, pre-trains machine learning models on extensive molecular databases, and establishes baseline performance metrics beforehand, ensuring that the subsequent compound discovery process has access to optimized models and high-quality reference data for accurate candidate identification
Solution Approach 2:
The patent implements feedback mechanisms where the system continuously evaluates its predictions against known pharmacological data and refines its models accordingly. The machine learning algorithms receive feedback from validated experimental results and use this information to improve their predictive accuracy, creating a closed-loop system that enhances measurement precision while maintaining high productivity through iterative model optimization
3Adaptability or versatility
If the vast expanse of chemical space is explored to find novel molecules, then the possibilities of discovering novel compounds increase, but the complexity of identifying the most promising candidate increases
Solution Approach 1:
The patent segments the vast chemical space into manageable subsets based on molecular scaffolds, functional groups, and structural similarities. Instead of evaluating all possible compounds simultaneously, the system divides the search space into discrete categories and applies specialized analysis methods to each segment, reducing the overall complexity while maintaining comprehensive coverage of novel compound possibilities
Solution Approach 2:
The patent introduces additional dimensions for analyzing molecular candidates beyond basic structural properties. The system evaluates compounds across multiple dimensions including pharmacokinetic properties, toxicological profiles, synthetic accessibility, and predicted biological activity, transforming the complex high-dimensional evaluation problem into a structured multi-criteria assessment that can be systematically optimized
Data Source
AI summary
A system and method that takes in a data set comprising molecular structure data and properties of interest, e.g., ADMET, EC50, IC50, etc., and determines the substructures that cause or do not cause the property of interest. The substructures may then be used to filter out potentially harmful new proposed/generated molecules or create a new data set of known active/inactive substructures of a property of interest that may fulfill other obligations. The system comprises a substructure extraction module which further comprises a scaffold extraction module and a comparison module. A scaffold extraction module clusters, searches, and extracts substructures in question while a comparison module compares the bioactivity of each molecule with and without each substructure in question to determine the substructures effect on the property of interest.